SCHEMBL20459265

SCHEMBL20459265

CCCCCCCCCCCCCCCCNC(=O)OCCC(C)(C)OCCC(C)(C)OC

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.55
ACHE P22303 14/20 0.53
EPHX2 P34913 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25514411 0.92 ACHE (0.51) EPHX1ACHEEPHX2
SCHEMBL20272872 0.87 EPHX1 (0.42) EPHX1ACHEEPHX2
SCHEMBL18699084 0.86 EPHX1 (0.44) EPHX1ACHE
SCHEMBL21226052 0.86 ACHE (0.39) EPHX1ACHEEPHX2
SCHEMBL19227183 0.85 EPHX1 (0.45) EPHX1ACHE
SCHEMBL19976555 0.84 CASP2 (0.51) EPHX1EPHX2
SCHEMBL20272887 0.83 EPHX1 (0.38) EPHX1ACHEEPHX2
SCHEMBL15150965 0.83 CHRNB2 (0.41) ACHE
SCHEMBL19227197 0.83 EPHX1 (0.42) EPHX1ACHE
SCHEMBL18699101 0.82 EPHX1 (0.42) EPHX1ACHEEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760477-B1 DI-ALIPHATIC SUBSTITUTED PEGYLATED LIPIDS ALNYLAM PHARMACEUTICALS INC (US) 2018-08-08 EP disclosed